ImpediMed is a leading brand in the field of bioimpedance spectroscopy (BIS) devices. These devices are designed to accurately and noninvasively aid in the early detection, assessment, and interventions for chronic diseases. By using ImpediMed's medical BIS devices, healthcare professionals can provide better care and improve outcomes for patients with conditions such as lymphedema and heart failure.

ImpediMed's flagship product is the SOZO® Digital Health Platform, which offers a range of applications such as L-Dex® Analysis for lymphedema, BodyComp™ Analysis, HF-Dex™ Analysis for heart failure, and segmental BodyComp™ Analysis. These applications provide valuable insights into a patient's condition, enabling personalized treatment plans and precise monitoring. ImpediMed also offers research devices, including the SFB7 ImpediVET Technology, for furthering scientific studies and advancements in the field.

For patients, ImpediMed provides resources and support through their website, including information on preventing lymphedema and managing heart failure. They also have a Find a Provider feature to help patients locate healthcare professionals experienced in utilizing ImpediMed's technology. ImpediMed is dedicated to improving patient outcomes through their innovative BIS devices and continues to lead the way in the field of medical technology